Tumour lysis syndrome with acute renal failure during imatinib therapy

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 573-574

  Ali, Ridvan ^a   Ozkalemkas, Fahir ^a   Ozkan, Atilla ^a   Ozcelik, Tulay ^a   Ozkocaman, Vildan ^a   Akdag, Ibrahim ^a   Ozan, Ulku ^a   Tunali, Ahmet ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acute renal failure; Cancer; Imatinib; Leukemia; Tumour lysis syndrome

Indexed keywords

ALLOPURINOL; ASPARAGINASE; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DIURETIC AGENT; FUROSEMIDE; HEMOGLOBIN; HYDROXYUREA; IMATINIB; PHOSPHORUS; POTASSIUM; PREDNISOLONE; UREA; URIC ACID; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DEHYDRATION; DRUG EFFECT; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; HUMAN; LETTER; MALE; PALLOR; PETECHIA; PRIORITY JOURNAL; PURPURA; RARE DISEASE; RETREATMENT; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

ANTINEOPLASTIC AGENTS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY NEOPLASMS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; TUMOR LYSIS SYNDROME;

EID: 33846702520     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.05.005     Document Type: Letter

References (7)

1. Cairo M.S., and Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127 (2004) 3-11
2. Annemas L., Moeremans K., Lamotte M., Garcia Conte J., van den Berg H., Myint H., et al. Incidence, medical resource utilization and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma 44 (2003) 77-83
3. Guilhot F. Indications for imatinib mesylate therapy and clinical management. Oncologist 9 (2004) 271-281
4. Vora A., Bhutani M., Sharma A., and Raina V. Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase. Ann Oncol 13 (2002) 1833-1834
5. Kitiyaraka C., and Atichartakarn V. Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571. Nephrol Dial Transplant 17 (2002) 685-687
6. Dann E.J., Fineman R., and Rowe J.M. Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia. J Clin Oncol 20 (2002) 353-355
7. Pou M., Saval N., Vera M., Saurian A., Sole M., Cervantes F., et al. Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia. Leuk Lymphoma 44 (2003) 1239-1241